Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

69.84 +0.36 (+0.52%)

Streaming Delayed Price Updated: 10:06 AM EDT, Mar 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

25 26 Next >

Unveiling 21 Analyst Insights On Boston Scientific ↗

June 18, 2024

Via Benzinga

Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal ↗

June 18, 2024

Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024.

Via Benzinga

Why Is Silk Road Medical (SILK) Stock Up 24% Today? ↗

June 18, 2024

Silk Road Medical stock is up on Tuesday after Boston Scientific announced its acquiring the company in a $1.26 billion deal.

Via InvestorPlace

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover ↗

June 18, 2024

The deal focuses on the company's stroke prevention product for patients with carotid artery disease.

Via Investor's Business Daily

Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific

June 18, 2024

From Silk Road Medical

Via GlobeNewswire

Check Out What Whales Are Doing With BSX ↗

June 07, 2024

Via Benzinga

How Is The Market Feeling About Boston Scientific? ↗

May 23, 2024

Via Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today ↗

May 22, 2024

Via Benzinga

Decoding 18 Analyst Evaluations For Boston Scientific ↗

May 15, 2024

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

June 14, 2024

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years ↗

June 03, 2024

Via Benzinga

Jim Cramer Recommends Buying This Sports Betting Company's Stock: 'I Think It's Terrific' ↗

May 17, 2024

Sports betting app DraftKings is "terrific," Cramer says. The company recently reported Q1 revenue of $1.18 billion, up 53% year-over-year.

Via Benzinga

Boston Scientific's Upside With Cardiology Devices Drives Momentum ↗

May 15, 2024

Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum.

Via Benzinga

$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗

May 01, 2024

Via Benzinga

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

(BSX) - Analyzing Boston Scientific's Short Interest ↗

April 25, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 15, 2024

Via Benzinga

MarketBeat Week in Review – 4/29 - 5/3

May 04, 2024

Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024

Via MarketBeat

Topics Economy Stocks

Citi Just Raised Its Price Target on These 3 Stocks ↗

May 04, 2024

Discover the three stocks enjoying boosted Citi price targets. Analysts believe they are primed for success, so it's time to start buying.

Via InvestorPlace

Needham Just Boosted Its Price Target on These 3 Stocks ↗

May 02, 2024

Amidst the uncertainty in the market at this time, it is best to rely on Needham price targets to make informed decisions.

Via InvestorPlace

Key Takeaways From Boston Scientific Analyst Ratings ↗

April 25, 2024

Via Benzinga

Boston Scientific Bucks the Medtech Slow Down and Raises Outlook

April 30, 2024

Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.

Via MarketBeat

Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗

April 26, 2024

Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.

Via Investor's Business Daily

Top 4 Health Care Stocks That May Plunge This Month ↗

April 26, 2024

Via Benzinga

Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating ↗

April 25, 2024

On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.

Via Investor's Business Daily

Wabtec Rumbles onto Stock Spotlight List. Check These Lists For Best Stocks To Watch And Buy ↗

April 24, 2024

Wabtec leads a diverse group climbing aboard the Stock Spotlight list, including defense and aerospace play TransDigm.

Via Investor's Business Daily

Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 24, 2024

Via Benzinga

Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday? ↗

April 24, 2024

Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the...

Via Benzinga

Topics Bonds

Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars ↗

April 24, 2024

Boston Scientific reports impressive Q1 earnings, with revenues of $3.86 billion, beating estimates. Cardiovascular segment leads with $2.4 billion sales, up 15.9%. Outlook: 2024 net sales growth...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.